×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [11]
中国医学科学院 北京... [4]
上海大学 [2]
吉林大学白求恩第一医... [2]
华南理工大学 [1]
内容类型
会议论文 [20]
发表日期
2018 [4]
2016 [3]
2015 [2]
2014 [4]
2013 [1]
2012 [3]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共20条,第1-10条
帮助
限定条件
内容类型:会议论文
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Xu, Nong
;
Shen, Lin
;
Dai, Guanghai
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Shi, Jianhua
;
Feng, Ji Feng
;
Shen, Lin
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Xu, Nong
;
Shen, Lin
;
Dai, Guanghai
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Shi, Jianhua
;
Feng, Ji Feng
;
Shen, Lin
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Cbcsg-10: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple negative breast cancer.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:
Shao Zhimin
;
Li, Junjie
;
Pang, Da
;
Wang, Changqing
;
Jiang, Jun
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/04
Randomized phase III trial of utidelone, a genetically engineered epothilone analog, in combination with capecitabine versus capecitabine alone for metastatic breast cancer patients with previous taxane and anthracycline treatment.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:
Xu, Binghe
;
Sun, Tao
;
Zhang, Qingyuan
;
Yuan, Zhongyu
;
Zhang, Pin
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/04
Outcomes of re-treatment with first-line trastuzumab plus taxane in patients (pts) with metastatic breast cancer (mBC) who relapsed after (neo)adjuvant trastuzumab: A prospective multicenter study.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:
Xu, Binghe
;
Hu, Xi-Chun
;
Zheng, Hong
;
Wang, Xiaojia
;
Zhang, Qingyuan
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/04
The use of CTCAE v3.0 in cancer clinical trial publications
会议论文
作者:
Zhang, Sheng
;
Hu, Xi-Chun
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/19
Lysophosphatidic Acid Signaling Is Required For The Normal Proliferation Of Postnatal But Not Embryonic Cardiomyocytes
会议论文
CIRCULATION RESEARCH, 2015-12-04
作者:
Wang, Fang
;
Liu, Si
;
Cai, Lin
;
Cong, Xiangfeng
;
Chun, Jerold
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/13
cardiomyocytes
proliferation
lysophosphatidic acid
LPA receptor
YAP
Phase II study of pseudomonas aeruginosa-mannose-sensitive hemagglutinin in combination with capecitabine for HER2-negative metastatic breast cancer pretreated with anthracycline and taxane
会议论文
作者:
Lv, Fangfang
;
Cao, Jun
;
Liu, Zhebin
;
Wang, Zhong Hua
;
Zhang, Jian
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/19
©版权所有 ©2017 CSpace - Powered by
CSpace